Percutaneous interventional mitral regurgitation treatment using the Mitra-Clip system

P Boekstegers, J Hausleiter, S Baldus, R S von Bardeleben, H Beucher, C Butter, O Franzen, R Hoffmann, H Ince, K H Kuck, V Rudolph, U Schäfer, W Schillinger, N Wunderlich, Germany Society of Cardiology Working Group on Interventional Cardiology Focus Group on Interventional Mitral Valve Therapy

    109 Citations (Scopus)


    The interventional treatment of mitral valve regurgitation by the MitraClip procedure has grown rapidly in Germany and Europe during the past years. The MitraClip procedure has the potential to treat high-risk patients with secondary mitral valve regurgitation and poor left ventricular function. Furthermore, patients with primary mitral valve regurgitation may be treated successfully by the MitraClip procedure in case of high surgical risk or in very old patients. At the same time it has been emphasised that the MitraClip interventional treatment is still at an early stage of clinical development. The largest clinical experience with the MitraClip procedure so far is probably present in some German cardiovascular centers, which here summarise their recommendations on the current indications and procedural steps of the MitraClip treatment. These recommendations of the AGIK and ALKK may present a basis for future development.

    Original languageEnglish
    JournalClinical research in cardiology : official journal of the German Cardiac Society
    Issue number2
    Pages (from-to)85-96
    Number of pages12
    Publication statusPublished - Feb 2014


    • Cardiac Catheterization
    • Consensus
    • Echocardiography, Three-Dimensional
    • Echocardiography, Transesophageal
    • Heart Valve Prosthesis
    • Heart Valve Prosthesis Implantation
    • Humans
    • Mitral Valve
    • Mitral Valve Insufficiency
    • Patient Selection
    • Prosthesis Design
    • Risk Assessment
    • Risk Factors
    • Treatment Outcome


    Dive into the research topics of 'Percutaneous interventional mitral regurgitation treatment using the Mitra-Clip system'. Together they form a unique fingerprint.

    Cite this